Brand Tone

Innovative and Scientific, Professional and Authoritative, Hopeful and Patient-Centric, Efficient and Transformative, Collaborative

Brand Values

• •Innovation
• •Patient-Centricity
• •Scientific Rigor & Precision
• •Efficiency and Speed
• •Collaboration
• •Transparency
• •Integrity
• •Compassion

Best Practices

• •Lead with Innovation, Support with Science: Always highlight the pioneering AI aspect (RADR® platform) but immediately back it up with concrete scientific achievements, data points, or clinical progress to maintain authority and credibility.
• •Maintain a Hopeful Yet Realistic Patient-Centric Narrative: Frame the technical advancements in terms of their ultimate benefit to patients. Use empowering language, but avoid over-promising, given the clinical-stage nature of the products.
• •Emphasize Efficiency and Transformation: Consistently weave in the message of how AI is making drug development faster, more cost-effective, and more precise compared to traditional methods. Use strong verbs that convey transformation and progress.
• •Be Transparent and Data-Oriented: When discussing progress, refer to data, clinical trial phases, and specific drug candidates. This reinforces the scientific and professional nature of the brand. Ensure information aligns with official press releases and investor communications.
• •Foster a Tone of Collaboration and Forward Momentum: Even in technical descriptions, convey a sense of partnership, shared mission, and continuous advancement. This reflects the company's values and its dynamic role in the evolving field of AI in medicine.

Social Perception

Pioneering/Innovative, Focused on Unmet Needs, Data-Driven, Potentially Disruptive, Clinical-Stage Investment

Copy Examples

• •Headline: Revolutionizing Oncology with AI: Faster Cures, Personalized for You. Body: At Lantern Pharma, we're not just developing cancer drugs; we're reinventing the entire process. Our RADR® AI platform analyzes billions of data points to uncover novel treatments and match them to the patients who will benefit most. Discover how we're accelerating the future of cancer therapy.
• •Headline: Hope, Powered by Data. Precision, Driven by AI. Body: For patients facing complex cancers, time and precision are everything. Lantern Pharma's AI-driven approach identifies unique vulnerabilities in tumors, paving the way for targeted therapies that were once unimaginable. We're committed to bringing new hope, faster.
• •Headline: Beyond the Hype: AI Delivering Real Results in Cancer Drug Development. Body: Lantern Pharma is translating the promise of artificial intelligence into tangible progress. Our RADR® platform has cut drug development timelines from years to months, moving promising candidates into clinical trials with unprecedented speed and cost-efficiency. See the science behind our success.
• •Headline: Collaborating for a Cancer-Free Future. Body: The fight against cancer demands a united front. Lantern Pharma partners with leading researchers and institutions, leveraging our AI expertise to unlock new therapeutic possibilities together. Join us in our mission to transform cancer care for patients worldwide.
• •Headline: Investing in a Smarter Path to Cancer Cures. Body: Lantern Pharma (NASDAQ: LTRN) is at the vanguard of a new era in biopharma. By harnessing AI, we're de-risking oncology R&D, identifying high-potential drug candidates, and accelerating the journey to regulatory approval. Learn about our vision for a more efficient and patient-focused future.